E-prescribing reaches critical mass: New technology eases compliance with DEA regulations while streamlining prescription workflows


When the Drug Enforcement Administration (DEA) introduced regulations for electronic prescribing of controlled substances (EPCS) in 2010, many providers worried that EPCS’s strict security stipulations would disrupt their prescribing workflows. Since then, New York State’s groundbreaking I-STOP legislation and the public debate about mandating EPCS in other states, has driven innovations in health technology that drive EPCS adoption.

In a recent webinar, Dan Borgasano and Matt Erich of Imprivata talk about Imprivata Confirm ID™, a single, comprehensive platform for EPCS, which eases compliance with DEA requirements while enabling a single, efficient workflow for all prescriptions. The speakers discuss the drivers of EPCS, regulatory and technology requirements, and features and capabilities of Imprivata Confirm ID. They also provide sources for additional information and answer audience questions about:

  • Provider identify proofing
  • Enabling supervised enrollment of credentials
  • Enforcing two-factor authentication, including Hands Free Authentication
  • Maintaining a comprehensive audit trail throughout the entire process

Get ready for EPCS in your organization. Watch the webinar recording or read the webinar transcript.